{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:06:07Z","timestamp":1759057567689,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.chroma.2019.460828","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T11:44:32Z","timestamp":1577360672000},"page":"460828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Two dimensional chromatography mass spectrometry: Quantitation of chiral shifts in metabolism of propranolol in bioanalysis"],"prefix":"10.1016","volume":"1617","author":[{"given":"Lukas C.","family":"Harps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Schipperges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bredendiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Wuest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Borowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-8300","authenticated-orcid":false,"given":"Maria Kristina","family":"Parr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2019.460828_bib0001","unstructured":"EMA, Investigation of chiral active substances, (1993)."},{"key":"10.1016\/j.chroma.2019.460828_bib0002","unstructured":"FDA, Development of new stereoisomeric drug, (1992)."},{"key":"10.1016\/j.chroma.2019.460828_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chroma.2018.05.062","article-title":"Enantioselective multiple heartcut two-dimensional ultra-high-performance liquid chromatography method with a Coreshell chiral stationary phase in the second dimension for analysis of all proteinogenic amino acids in a single run","volume":"1562","author":"Woiwode","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2019.460828_bib0004","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4155\/bio.15.119","article-title":"Simultaneous and stereospecific analysis of warfarin oxidative metabolism using 2D LC\/Q-TOF","volume":"7","author":"Joseph","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.460828_bib0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0090-9556(25)07252-6","article-title":"Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6: studies using the yeast-expressed enzyme and NADPH\/O2 and cumene hydroperoxide-supported reactions","volume":"24","author":"Bichara","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chroma.2019.460828_bib0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2125.1995.tb04472.x","article-title":"Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers\u2013N-desisopropylation is mediated mainly by CYP1A2","volume":"39","author":"Yoshimoto","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.chroma.2019.460828_bib0007","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0090-9556(25)08435-1","article-title":"Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase","volume":"22","author":"Masubuchi","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chroma.2019.460828_bib0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-2797(00)00174-5","article-title":"Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes","volume":"127","author":"Narimatsu","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.chroma.2019.460828_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF00562500","article-title":"Pharmacokinetics of dextro-, leavo-and racemic propranolol in man","volume":"4","author":"George","year":"1972","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.chroma.2019.460828_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1968.tb07949.x","article-title":"The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias","volume":"34","author":"Barrett","year":"1968","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chroma.2019.460828_bib0011","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5381.1971.tb07171.x","article-title":"Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol","volume":"43","author":"Fitzgerald","year":"1971","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chroma.2019.460828_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-4347(00)83045-5","article-title":"Enantioselective drug monitoring of (R)- and (S)- propranolol in human plasma via derivatization with optically active (R,R)-O,O-diacetyl tartaric acid anhydride","volume":"487","author":"Lindner","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.chroma.2019.460828_bib0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2003.11.029","article-title":"Fast enantiomeric separation of propranolol by affinity capillary electrophoresis using human serum albumin as chiral selector: application to quality control of pharmaceuticals","volume":"507","author":"Mart\u0131\u0301nez-Pla","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2019.460828_bib0014","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1002\/elps.200900216","article-title":"Enantioselective analysis of propranolol and 4-hydroxypropranolol by CE with application to biotransformation studies employing endophytic fungi","volume":"30","author":"Borges","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2019.460828_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-4347(96)00313-1","article-title":"Stereoselective high-performance liquid chromatography determination of propranolol and 4-hydroxypropranolol in human plasma after pre-column derivatization","volume":"692","author":"Wu","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.chroma.2019.460828_bib0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0378-4347(00)82118-0","article-title":"Simultaneous determination of propranolol and 4-Hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid-chromatography","volume":"527","author":"Schaefer","year":"1990","journal-title":"J. Chromatogr.-Biomed. Appl."},{"key":"10.1016\/j.chroma.2019.460828_bib0017","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0731-7085(91)80029-9","article-title":"High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasma","volume":"9","author":"Miller","year":"1991","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2019.460828_bib0018","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0090-9556(25)08193-0","article-title":"Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes","volume":"21","author":"Masubuchi","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chroma.2019.460828_bib0019","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2116\/analsci.14.823","article-title":"Uniform-sized molecularly imprinted polymer material for propranolol. Recognition of propranolol and its metabolites","volume":"14","author":"Haginaka","year":"1998","journal-title":"Anal. Sci."},{"key":"10.1016\/j.chroma.2019.460828_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0021-9673(97)00919-9","article-title":"Enantiomeric separation of propranolol and selected metabolites by using capillary electrophoresis with hydroxypropyl-\u03b2-cyclodextrin as chiral selector","volume":"793","author":"Pak","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2019.460828_bib0021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1255\/ejms.923","article-title":"Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry","volume":"14","author":"Kuuranne","year":"2008","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2019.460828_bib0022","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2019.460828_bib0023","first-page":"13","article-title":"Superficially porous particles: perspectives, practices, and trends","volume":"32","author":"Fekete","year":"2014","journal-title":"LCGC N. Am."},{"key":"10.1016\/j.chroma.2019.460828_bib0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aca.2017.10.014","article-title":"The differences in matrix effect between supercritical fluid chromatography and reversed phase liquid chromatography coupled to ESI\/MS","volume":"1000","author":"Svan","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2019.460828_bib0025","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","volume":"86","author":"Gu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2019.460828_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/chir.530010105","article-title":"Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)-Propranolol and (R,S)-Propranolol","volume":"1","author":"Lindner","year":"1989","journal-title":"Chirality"},{"key":"10.1016\/j.chroma.2019.460828_bib0027","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-3565(24)39177-3","article-title":"CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences","volume":"294","author":"Johnson","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chroma.2019.460828_bib0028","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cbi.2010.12.014","article-title":"Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19","volume":"189","author":"Narimatsu","year":"2011","journal-title":"Chem. Biol. Interact."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967319312993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967319312993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:52:25Z","timestamp":1758261145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967319312993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":28,"alternative-id":["S0021967319312993"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2019.460828","relation":{},"ISSN":["0021-9673"],"issn-type":[{"type":"print","value":"0021-9673"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two dimensional chromatography mass spectrometry: Quantitation of chiral shifts in metabolism of propranolol in bioanalysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2019.460828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"460828"}}